Biomarkers in the Nose, Throat, and Lung Tissue of Smokers and Non-Smokers
NCT00897364 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 112
Last updated 2020-05-15
Summary
RATIONALE: Studying samples of tissue from smokers and non-smokers in the laboratory may help doctors identify and learn more about biomarkers related to cancer.
PURPOSE: This phase II study is looking at biomarkers in the nose, throat, and lung tissue of smokers and non-smokers.
Conditions
- Lung Cancer
- Precancerous Condition
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
University of Colorado, Denver
lead OTHER
Principal Investigators
-
York E. Miller, MD · University of Colorado, Denver
Eligibility
- Min Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2000-05-31
- Primary Completion
- 2009-12-01
- Completion
- 2009-12-01
Countries
- United States
Study Locations
More Related Trials
-
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
NCT00450281 ·Status: COMPLETED
-
Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients
NCT05415358 ·Status: ACTIVE_NOT_RECRUITING
-
Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers
NCT00899262 ·Status: UNKNOWN
-
Salivary Biomarkers for Non-small Cell Lung Cancer Detection
NCT02294578 ·Status: UNKNOWN
-
A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer
NCT04951154 ·Status: COMPLETED
-
'Lung Health Check' Biomarker Study
NCT04957433 ·Status: UNKNOWN
-
Circulating Tumor Cells in Non-Small Cell Lung Carcinoma
NCT01830426 ·Status: COMPLETED
-
Lung EpiCheck Biomarkers Development Study
NCT06245876 ·Status: RECRUITING
-
Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer and Discovery of New Biomarkers
NCT03658460 ·Status: COMPLETED
-
Liquid Biopsy for Early Non-small Lung Cancer Detection
NCT05462795 ·Status: COMPLETED
-
The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer
NCT02380196 ·Status: COMPLETED
-
MRI and Biomarkers for Lung Nodules Detected During Lung Cancer Screening
NCT05699213 ·Status: RECRUITING
-
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
NCT01580982 ·Status: RECRUITING
-
Specimen Banking From Patients With Lung Cancer
NCT01585675 ·Status: RECRUITING
-
Detection of Genetic Markers of Lung Cancer
NCT00280202 ·Status: RECRUITING
-
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01517971 ·Status: COMPLETED
-
Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.
NCT06016569 ·Status: RECRUITING ·Phase: NA
-
Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC)
NCT01173458 ·Status: COMPLETED
-
Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer
NCT00019201 ·Status: COMPLETED ·Phase: NA
-
Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
NCT00185913 ·Status: COMPLETED
-
The Role of Interventional Pulmonology, Microbiota and Immune Response in the Patient With Lung Cancer
NCT05164445 ·Status: COMPLETED ·Phase: NA
-
Maximizing Benefit of Lung Cancer Screening Incidental Findings of Cardiovascular, Respiratory and Breast Measures
NCT05900544 ·Status: WITHDRAWN ·Phase: NA
-
Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker
NCT01700257 ·Status: COMPLETED ·Phase: NA
-
Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal Carcinoma
NCT06762470 ·Status: ACTIVE_NOT_RECRUITING
-
Using e-Nose Technology to Identify Early Lung Cancer
NCT04734145 ·Status: ACTIVE_NOT_RECRUITING